These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14993096)

  • 1. Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects.
    Larsen AK; Brennum LT; Egebjerg J; Sánchez C; Halldin C; Andersen PH
    Br J Pharmacol; 2004 Mar; 141(6):1015-23. PubMed ID: 14993096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
    Chalon S; Tarkiainen J; Garreau L; Hall H; Emond P; Vercouillie J; Farde L; Dasse P; Varnas K; Besnard JC; Halldin C; Guilloteau D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):81-7. PubMed ID: 12490578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).
    Li Q; Ma L; Innis RB; Seneca N; Ichise M; Huang H; Laruelle M; Murphy DL
    J Pharmacol Exp Ther; 2004 Feb; 308(2):481-6. PubMed ID: 14610240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of S-citalopram and paroxetine discriminates between species.
    Elfving B; Wiborg O
    Synapse; 2005 Mar; 55(4):280-2. PubMed ID: 15668984
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.
    Jarkas N; McConathy J; Voll RJ; Goodman MM
    J Med Chem; 2005 Jun; 48(13):4254-65. PubMed ID: 15974579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice.
    Perez XA; Andrews AM
    Anal Chem; 2005 Feb; 77(3):818-26. PubMed ID: 15679349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
    Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
    Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization and visualization of the glial serotonin transporter.
    Inazu M; Takeda H; Ikoshi H; Sugisawa M; Uchida Y; Matsumiya T
    Neurochem Int; 2001 Jul; 39(1):39-49. PubMed ID: 11311448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
    Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
    J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
    Ravna AW; Sylte I; Dahl SG
    J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter.
    Agnel M; Esnaud H; Langer SZ; Graham D
    Biochem Pharmacol; 1996 May; 51(9):1145-51. PubMed ID: 8645336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.
    Pullar IA; Carney SL; Colvin EM; Lucaites VL; Nelson DL; Wedley S
    Eur J Pharmacol; 2000 Oct; 407(1-2):39-46. PubMed ID: 11050288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
    Benmansour S; Owens WA; Cecchi M; Morilak DA; Frazer A
    J Neurosci; 2002 Aug; 22(15):6766-72. PubMed ID: 12151556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.